← Open Payments lookup

LISA BAKER: Open Payments

NPI 1912389503 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,787 in 92 payments from 14 companies in 2025. Trend: 2023 $2,250 · 2024 $1,975 · 2025 $1,787

Food & beverage: $1,787
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.23$372
ABBVIE INC.12$228
E.R. Squibb & Sons, L.L.C.11$179
Otsuka America Pharmaceutical, Inc.8$172
Axsome Therapeutics, Inc.4$149
Janssen Pharmaceuticals, Inc7$149
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$144
Teva Pharmaceuticals USA, Inc.5$99
Lundbeck LLC4$83
LivaNova USA, Inc.2$74

Products named: INGREZZA, VRAYLAR, REXULTI, COBENFY, Auvelity, INVEGA SUSTENNA, CAPLYTA, AUSTEDO XR.

Industry payments across LA — which companies pay providers there.